Key Documents

View All Documentation

L121

Levallorphan tartrate salt

Name: Levallorphan tartrate salt
Brand: SIGMA

≥98% (HPLC), powder

Synonym(s):

17-(2-Propenyl)morphinan-3-ol tartrate

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₉H₂₅NO · C₄H₆O₆

CAS Number:

71-82-9

Molecular Weight:

433.49

NACRES:

NA.77

PubChem Substance ID:

24278815

UNSPSC Code:

12352200

EC Number:

200-767-3

MDL number:

MFCD00210203

Assay:

≥98% (HPLC)

Form:

powder

Quality level:

100

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

Quality Level

100

assay

≥98% (HPLC)

form

powder

optical activity

[α]22/D −35°, c = 0.38 in H₂O(lit.)

color

white to beige

solubility

H₂O: 5 mg/mL, clear

originator

Roche

SMILES string

O[C@H]([C@@H](O)C(O)=O)C(O)=O.[H][C@@]12CCCC[C@@]13CCN(CC=C)[C@@H]2Cc4ccc(O)cc34

InChI

1S/C19H25NO.C4H6O6/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19;5-1(3(7)8)2(6)4(9)10/h2,6-7,13,16,18,21H,1,3-5,8-12H2;1-2,5-6H,(H,7,8)(H,9,10)/t16-,18+,19+;1-,2-/m01/s1

InChI key

FWMLYVACGDQRFU-ZTMWJVNESA-N

Gene Information

human ... OPRD1(4985), OPRM1(4988)

Description

Biochem/physiol Actions

Partial agonist (antagonist) at μ and δ opioid receptors.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Disclaimer

Photosensitive

pictograms

GHS07

signalword

Warning

hcodes

H302

pcodes

P264 - P270 - P301 + P312 - P501

Hazard Classifications

Acute Tox. 4 Oral

Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles.

Ying-Chen Chen et al.

International journal of nanomedicine, 10, 7265-7274 (2015-12-15)

To alleviate the inherent problems of amphotericin B (AmB), such as poor water solubility and nephrotoxicity, a novel self-assembling mixed polymeric micelle delivery system based on lecithin and combined with amphiphilic polymers, Pluronic(®), Kolliphor(®), d-alpha tocopheryl polyethylene glycol succinate, and

Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.

Ling-Chun Chen et al.

International journal of nanomedicine, 11, 1557-1566 (2016-05-05)

Quercetin (Que) is known to have biological benefits including an anticancer effect, but low water solubility limits its clinical application. The aim of this study was to develop a lecithin-based mixed polymeric micelle (LMPM) delivery system to improve the solubility

A one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®.

Anushree Seth et al.

International journal of nanomedicine, 7, 5129-5136 (2012-10-12)

The influence of morphology and surface properties on the therapeutic efficacy of degradable polymeric microparticles has not been well understood. One of the primary reasons for this is the limited ability to fabricate microparticles with controlled morphology and surface properties.

View All Related Papers

Global Trade Item Number

SKU	GTIN
L121-5MG	04061833949238